Article Details

Jefferies Financial Group Weighs in on Ultragenyx Pharmaceutical Inc.'s Q2 2021 Earnings ...

Retrieved on: 2021-05-10 05:37:30

Tags for this article:

Click the tags to see associated articles and topics

Jefferies Financial Group Weighs in on Ultragenyx Pharmaceutical Inc.'s Q2 2021 Earnings .... View article details on hiswai:

Excerpt

BlackRock Inc. now owns 5,462,185 shares of the biopharmaceutical company's stock valued at $621,923,000 after purchasing an additional 174,709 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up